EU HTA Regulation: Companies Want Bigger Role In Shaping Assessments
A bigger role for companies in the scoping process for the imminent EU-level joint clinical assessments is essential for patient access, according to industry.
A bigger role for companies in the scoping process for the imminent EU-level joint clinical assessments is essential for patient access, according to industry.